He Zhou

Dr. He Zhou

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2025 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
HZHe Zhou
He Zhou
SASolange Abdulnour-Nakhoul
Solange Abdulnour-Nakhoul
LHL. Lee Hamm
L. Lee Hamm
NNNazih L. Nakhoul
Nazih L. Nakhoul
Our study revealed the complex regulation of NH3/NH4+ transport, highlighting the roles of Rhbg, CA-IV, and environmental factors such as CO2 concentration. These interactions are critical to our understanding of NH3/NH4+ transport and regulation. Our findings lay a strong foundation for future investigations into the molecular dynamics among these transport proteins and their physiological significance. These studies are essential to fully understand how these mechanisms influence renal ammonia handling, urinary acidification, and systemic pH balance.

19 April 2026 in Cells
Verified
Journal Article
Open access
PDF file
SHSofie-Yasmin Hassan
Sofie-Yasmin Hassan
SSSimeon Santourlidis
Simeon Santourlidis
TFThomas W. Flanagan
Thomas W. Flanagan
SHSarah-Lilly Hassan
Sarah-Lilly Hassan
HZHe Zhou
He Zhou
Mohamed HassanMohamed Hassan
Mohamed Hassan
Head and neck mucosal melanoma (HNMM) arises in the nasal and oral cavities and has the propensity to metastasize to local and distant body sites. HNMM is also notable for its resistance to available therapeutics. The rarity of this disease makes it difficult to conduct large-scale clinical studies to develop standard treatment protocols. In contrast to cutaneous melanoma, c-Kit-dependent pathways are well studied in HNNMM and provide a potential therapeutic target. We identified and isolated genetically distinct subpopulations with stem cell characteristics in HNMM samples bearing Kit wild-type and mutations. Functional analysis of these subpopulations reveals that, in addition to expressing the stem cell marker proteins CD20, CD117, CD133, and CD166, these subpopulations are characterized by self-renewal potential, migratory capacity, and resistance to Kit inhibitors such as Imatinib. Immunofluorescence staining and inhibition experiments demonstrate that the maintenance and resistance of HHMM subpopulations to Kit inhibitors is mediated by the Kit signal to the PI3K signaling pathway. The KIT signal to the PI3K signaling pathway does not result exclusively from a KIT mutation localized to Exon 17, but can also be triggered by mutations localized to Exons 11 and 13. In the present study, we identify and characterize an HNMM subpopulation with stemness properties in patients with c-Kit wild-type and mutation, and demonstrate for the first time the mechanisms by which the CD117+/CD133+ HNMM subpopulations survive and confer resistance to the specific inhibitor of c-Kit mutation.